FDA Roundup: January 10, 2025
FDA Roundup: January 10, 2025
http://www.fda.gov/news-events/press-announcements/fda-roundup-january-10-2025
FDA Roundup: January 7, 2025
FDA Roundup: January 7, 2025
http://www.fda.gov/news-events/press-announcements/fda-roundup-january-7-2025
FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy: FDA Safety Communication
FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials
FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials
http://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-including-tissue-biopsies-clinical-trials
FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions
FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions
http://www.fda.gov/news-events/press-announcements/fda-proposes-framework-advance-credibility-ai-models-used-drug-and-biological-product-submissions
FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices
FDA Issues Comprehensive Draft Guidance for Developers of Artificial Intelligence-Enabled Medical Devices
http://www.fda.gov/news-events/press-announcements/fda-issues-comprehensive-draft-guidance-developers-artificial-intelligence-enabled-medical-devices
FDA Roundup: January 3, 2025
FDA Roundup: January 3, 2025
http://www.fda.gov/news-events/press-announcements/fda-roundup-january-3-2025